Effects of lipid-modification on the isolated membrane of catecholamine storage vesicles.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001692:Biological Transport; D002395:Catecholamines / Q000032:analysis / Q000037:antagonists & inhibitors / Q000378:metabolism*; D002417:Cattle; D002463:Cell Membrane Permeability / Q000187:drug effects; D002855:Chromatography, Thin Layer; D005227:Fatty Acids; D006868:Hydrolysis; D066298:In Vitro Techniques; D008244:Lysophosphatidylcholines / Q000494:pharmacology; D008274:Magnesium / Q000494:pharmacology; D008566:Membranes / Q000201:enzymology*; D009638:Norepinephrine / Q000378:metabolism; D009829:Oleic Acids / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010740:Phospholipases / Q000494:pharmacology; D010743:Phospholipids / Q000378:metabolism* / Q000494:pharmacology; D011506:Proteins / Q000032:analysis; D012710:Serum Albumin, Bovine
D002395:Catecholamines; D005227:Fatty Acids; D008244:Lysophosphatidylcholines; D009829:Oleic Acids; D010743:Phospholipids; D011506:Proteins; D012710:Serum Albumin, Bovine; D000255:Adenosine Triphosphate; D010740:Phospholipases; D000251:Adenosine Triphosphatases; D008274:Magnesium; D009638:Norepinephrine